Perioperative Medicine Flashcards
What are the advantages and disadvantages of Warfarin?
Advantages
Wide range of indications
Preferred in high-risk patients (especially mechanical valves)
Long safety history
Cheap, widely available antidote
Easy monitoring of degree of anticoagulation
No gastrointestinal upset (2% dabigatran/rivaroxaban)
Inexpensive
Single daily doseN
DISADVANTAGES
Need for monitoring
Highly variable dosing
Increased requirement for bridging
Food interactions
Drug interactions
Initially procoagulant
Slow onset
Long half-life
Increased risk of intracranial bleed (50%)
Possibly increased life-threatening bleed (25%)
What are the indications for NOACS / DOACS?
Only licensed for:
Non valvular AF (non inferior / decreased ICH)
Primary prevention VTE prophylaxis post Hip / Knee Surgery
Secondary prevention in other VTE
How does Warfarin , Dabigatran and Rivaroxaban Act?
Warfarin INHIBITS the epoxide reductase enzyme which is required to recycle vitamin K and is ESSENTIAL for production of gamma carboxylated coagulation factors. INDIRECT MECHANISM so takes time.
DABIGATRAN - directly inhibits THROMBIN (Factor 2) - it is a PRODRUG
RIVAROXABAN are DIRECT INhibitors of Factor Xa
How do you brige warfarin perioperatively?
Mounting evidence suggests bridging Warfarin increases major bleeding and cardiovascular events without a decrease in thromboembolic events.
1) Warfarin should not be interrupted for procedures of low risk
2) Patients at low VTE risk should not be Bridged
3) In patients at highest risk of VTW , but not excessive bleeding risk - consider Bridging
4) intermediate risk - individual risk assessment!
Warfarin needs to be ceased 5 days prior to OT.
How do you bridge DOACs?
Not recommended as the duration for the drug to be withheld before surgery is short and restoration of clinical effect is rapid and without PROCOAGULANT effect . Can be contemmplated in patient who has HIGH risk and requires prolonged preoprtative cessation .
How do you quantify Thromboembolic risk ?
- Divided in 3 groups
- Mechanical Heart Valve
- every Mitral + Some Aortic
- AF
- CHA2DS2VASc
- Previous VTE
- Mechanical Heart Valve
What is your approach to reversal of anticoagulants?
Depends on degree of bleeding and if it is life threatening
MINIMAL BLEEDING
- discontinue anticoagulant
- spontaneous resolution over time
- Vitamin K for warfarin
SEVERE BLEEDING
- Discontinue anticoagulant
- Supportive care (iv fluids, blood products - platelts )
- Activated charcoal
- Consider dialysis (dabigatran)
- DOAC reversal (dabigatran - IDARUCIAZUMAB)
- Consider Tranexamic acid 15-30mg/kg
- Prothrombin X 50iu/kg
- (haem advice - rfVII 90mck/kg or FEIBA
What is in Prothrombin X
What is in FFP
Freeze dried powder of FII IX X from plasma of donors
Vials contain 500IU
Contraindications are DIC or Thrombosis
FFP
Seperated and frozen plasma <18hrs
150-300 ml
Has Factors 2 9 10 7
Should be ABO compatible with patients Red Cells
Transfusion reaction, volume (15ml/kg)
What are the most common inherited bleeding disorders?
Haemophilia A, B or C (F8, F9 F11 def)
and
VWD 1 , 2a-d , 3 (quan, qual, none)
Discuss Haemophilia and its management
Classified as A, B or C depending on deficieny 8,9,11
A and B are X linked recessive - males affected, female carry
~1/3 have no family hx
Factors 8 and 9 important in intrinsic pathway ->thrombin
Routine clotting screen may be normal - maybe prolonged APTT
Definitive diagnosis with factor assay.
Treatment
- Factors and blood products*
- recombinant factors VII and IX (A and B) - free from disease
- expensive!
- must be screened for factor inhibitors! if high risk then need Factor Eight Inhibitor Bypass Assay (FEIBA)
CRYOPRECIPITATE (VIII, VWF, X111, fibrinogen)
PROTHROMBIN X (II, VII, IX, X, protein c and s) (replaced by specific factors)
Recombinant factor VIIa (binds platelets and activated X - generates thrombin)
FFP not really used anymore
Pharmacological
1) DDAVP - released vWF increasing VIII levels (mainly A and VWD)
2) Tranexamic acid - inhibits conversion of plasminogen to plasmin.
Discuss the managment of VWD
most common inherited bleeding disorder incidence 1/100 but only clinically relevant 1/10000
VWF normally released from endothelium - binds factor 8, decreasing its clearance also helps with platelet adhesion and aggregation.
3 types 1,2,3
1 = quantative problem
2 = qualitative problem (A-D)
3 = no VWF factor
Diagnosis
What is in CRYOPRECIPITATE
VIII
VWF
XIII
FIBRINOGEN
Define Prehabilitation
What are the components
What is the current evidence base
Prehabilitation is a preoperative conditioning intervention that aims to prevent or attenuate surgery-related functional decline and its consequences.
“multi modal” prehabilitation comprises of physical, nutritional, and psychological
Goals of nutritional = promote anabolism avoid malnutrition
Evidence shows a positive effect of prehabilitation on perioperative fitness BUT had not yet shown improvement in post op complications, length of stay, tumour progression, response to medical treatment and survival.
Should be personalized approach targeting high risk patients
Do you postpone surgery (cancer) to prehabilitate?
Screen (DASI, 6mWD) + HADS -> Assess -> Intervene –> Re-assess
How would you classify severity of asthma?
Define the following terms
FEV1
FVC
FEV1/ FVC Ratio
DLCO
FEF 25-75%
Maximum voluntary oxygenation